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The over-expression of recombinant protein in E. coli frequent-
ly results in the formation of insoluble aggregates, commonly
referred to as inclusion bodies (IBs). It was widely believed that
within the IBs the proteins were misfolded and functionally
inactive, until a number of studies revealed that for some
proteins there is at least a population within the IBs that are
functionally competent or contain functionally competent
domains
[1] and structurally native folds.
[2] More-recent studies
have focused on the similarities between IBs and amyloid fi-
brils,
[3] such as those found in a number of diseases including
localized conditions such as Alzheimer’s and Huntington’s as
well as systemic conditions including reactive systemic amyloi-
dosis and dialysis-related amyloidosis.
[4] Interestingly, these
studies have revealed that, upon the expression of some pro-
teins in E. coli, the IBs formed possess many of the properties
associated with amyloid deposits, including the characteristic
spectral changes associated with the binding of the dyes
Congo Red and Thioflavin T (ThT).
[4] Similarly, structural studies
reveal the presence of cross-b structures
[3a] and a local molecu-
lar geometry identical to that of fibrils.
[5] These observations
have led to the speculation that IBs and amyloid deposits
could share a common functional role, namely the sequestra-
tion of misfolded protein to prevent damage to the host. Here,
we report on studies of IBs composed of b2-microglobulin
(b2m) that are formed upon expression in E. coli and compare
their amyloid properties with those of b2m fibrils similar to
those found in patients suffering from dialysis-related amyloi-
dosis.
The fluorescence emission spectrum of ThT is widely used as
an indicator for the formation of amyloid fibrils.
[6] To ascertain
whether b2m IBs possess the necessary structural properties to
bind ThT, emission spectra were recorded in the presence of
IBs, b2m fibrils created by acid precipitation and soluble b2m
(Figure 1). Both the b2m fibrils and IBs showed enhanced fluo-
rescence at 485 nm compared with the soluble b2m. Interest-
ingly, ThT fluorescence for the IBs was only 11% of that of the
fibrillar material. This suggests that, within the IBs, either only
a fraction of the protein exists in a fibrillar form capable of en-
hancing fluorescence or that the b2m adopts a conformation
that results in a lower enhancement of fluorescence than
when bound to fibrillar structures.
To characterize the differences between the IBs and fibrillar
b2m at the molecular level, magic-angle spinning (MAS) solid-
state NMR measurements were performed. Using
13C/
13Ct w o -
dimensional proton-driven spin diffusion (PDSD) MAS NMR
spectroscopy,
[7] we were able to map out connectivities be-
tween proximal
13C atoms. This allowed for resonances to be
assigned to particular sites within the amino acids of b2mi n
fibrils and IBs on the basis of published random-coil chemical
shifts obtained in solution
[8] (Figures S2 and S3) and provided
insights into the local conformation and electrostatic environ-
ment.
The PDSD
13C/
13C correlation spectrum of the fibrillar b2m
(Figure 2, blue contours) shows line widths of ~0.5 ppm, which
are comparable with those observed for other
13C/
15N-labeled
fibrillar systems.
[9] As expected for the short mixing times em-
ployed, the spectrum is dominated by correlations between
adjacent carbon atoms and other intraresidue transfers. The
spectrum is relatively crowded due to the overall size of the
protein; however, the resonances are sufficiently well resolved
to be assigned to specific amino acid types and, in favorable
cases, to particular sites within the protein. These assignments
are consistent with a recently published partial assignment of
long, straight form of fibrillar b2m in the solid state.
[10]
The spectrum of b2m IBs (Figure 2A, red contours) is domi-
nated by intense protein resonances that arise from b2m
within the IBs. There is no evidence of other molecular species
Figure 1. ThTemission spectra in 1 mgmL
1 solutions of b2m fibrils (c), in-
clusion bodies (····) and monomeric b2m( a). ThT was excited at a wave-
length of 440 nm.
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in IB preparations of other systems.
[5] The lack of resonances
from these species in direct excitation spectra (data not
shown) indicates that this is due to their absence not just the
selective observation of immobile components by crosspolari-
zation. The spectra of IBs are again dominated by intraresidue
crosspeaks; however, these are significantly more intense than
the fibrillar b2m peaks. The efficient proton driven spin diffu-
sion and crosspolarization throughout the spectra suggests
that the dipolar couplings within the IB sample are stronger
than those in the fibrillar material, and this implies that the
protein exhibits less mobility. This efficient proton-driven spin
diffusion also leads to a number of additional crosspeaks
within the IB spectrum compared to the fibrillar material. In
particular, significant intensity is apparent at sites that corre-
spond to correlations between sites in the side chains contain-
ing carboxylic/carboxamide groups (Asp/Glu/Asn/Gln) at 58–25
and 175–185 ppm and correlations between the aromatic side
chains (Phe/Tyr) and the corresponding b-carbon atoms (~130,
30 ppm; Figure S3).
[8] In addition, correlations between reso-
nances attributed to aliphatic side chains, in particular Ile,
show significantly enhanced intensity.
The resonances observed in the IB spectrum are significantly
broader than those observed in the fibrillar spectrum. We attri-
bute this increase to the lower mobility within the IBs, which
results in an increase in the homogeneous line width. This is
consistent with the enhanced spin diffusion observed through-
out the PDSD spectra of the IBs. Based on the earlier percep-
tion that IBs are composed of misfolded protein, it was expect-
ed that significant inhomogeneous broadening would have
been observed due to the structural heterogeneities within the
sample. However, resonances can be resolved in the IB spectra
with line widths of 1.0 ppm, similar to those observed in other
noncrystalline, yet structurally homogeneous fibrillar systems.
[9]
The observed increase in homogeneous line width is further
supported by inspection of the resonances along the diagonal.
It is expected that inhomogeneous broadening would lead to
a distribution of resonances along the diagonal, whilst an in-
crease in the homogeneous line width would result in a broad-
ening of the diagonal. Comparison of the diagonal resonances
in the fibrillar and IB spectra shows a clear increase in line
width from ~0.5 to 1.2 ppm (Figure 2B); this is consistent with
an increase in homogeneous line width.
The enhanced crosspeak intensity and larger line width ob-
served in the IB spectrum suggest significant dynamic differen-
ces between the fibrillar and IB forms of b2m. In addition, there
are noticeable differences in the positions of a number of reso-
nances, thus suggesting differences in local structure or envi-
ronments. These could be responsible for the lower ThT fluo-
rescence that is observed upon the binding of ThT to the IBs.
In summary, our studies of b2m fibrils and inclusion bodies
show marked differences both in their response to ThT binding
and, at a molecular level, their structure and dynamics, as
revealed by MAS NMR spectroscopy. These findings contrast
with recent studies of IBs composed of the fungal prion pro-
tein Het-S, a protein with an intrinsic propensity to form amy-
loid fibrils. Solid-state NMR studies of Het-S IBs have indicated
that, at a molecular level, the protein adopts a conformation
identical to that of the fibrillar Het-S with little structural heter-
ogeneity whilst electron-microscopy and dye-binding assays
confirm the fibrillar nature of the material.
[5]
The observations on b2m suggest that formation of fibrillar
structures is not the default aggregation pathway and that
other outcomes are possible. Indeed, it is widely acknowl-
edged from in vitro experiments
[11] that b2m requires external
factors to promote fibril formation. This leads us to suggest
that the propensity of a protein to adopt a fibrillar structure
whilst being expressed in E. coli reflects an individual protein’s
intrinsic potential to adopt a conformation that promotes fi-
brillogenesis. Our observations contrast with earlier molecular
studies of IBs
[3a,5,12] that were conducted on proteins known to
readily adopt a fibrillar structure and thus can be expected to
form fibrils following expression. This leads us to conclude that
during expression not all proteins adopt the necessary inter-
Figure 2. A) Expansion of the 100 ms proton-driven spin-diffusion homonu-
clear
13C/
13C correlation spectra of b2m acid produced fibrils (blue) and IBs
(red). Spectra were recorded at 58C with a MAS spinning frequency of
15 kHz and plotted with the lowest contour just above the noise threshold
and subsequent levels at multiples of 1.625. (Non-superimposed spectra are
given in the Supporting Information.) B) 1D slice through the 2D spectrum
at 67 ppm showing differences in line width and resonance positions of the
fibrils and IBs, the diagonal peak is indicated by an asterisk.
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states that favor highly dense aggregates composed of struc-
tured protein.
Experimental Section
Preparation of b2m inclusion bodies and monomeric b2m: The
b2m labeled with
13C and
15N was expressed to inclusion bodies in
BL21(DE3) E. coli transformed with a pET11a plasmid encoding the
human form of b2m. The bacteria were grown on M9 salts (1 L)
containing uniformly labeled [
13C]glucose and [
15N]ammonium
chloride (Cambridge Isotopes Ltd.) until an OD600 of 1.0 was
reached, at which point b2m expression was induced by the addi-
tion of isopropyl-b-d-thiogalactopyranoside to a final concentration
of 1 mm. After a further 16 h, the bacteria were harvested by cen-
trifugation (8983g, 20 min). The bacteria were broken by using a
probe sonicator (10 min), and the insoluble material was pelleted
by centrifugation (16000g, 20 min). The pellet was washed with
wash buffer (2 25 mL; 50 mm TRIS, 100 mm NaCl, 4.2 mm MgCl,
0.5% Triton-X100, pH 8.0) containing lysozyme and DNaseI (Sigma).
The pellet was subjected to a further five washes with wash buffer
to give the final inclusion body sample.
To regenerate monomeric b2m fibril formation, the inclusion
bodies were homogenized in solubilization buffer (8m urea, 50 mm
2-morpholinoethane sulfonic acid, 0.1 mm ethylenediaminetetraa-
cetate (EDTA), 0.2 mm dithiothreitol), stirred overnight, and clarified
by centrifugation. The solubilized b2m was refolded by slow dilu-
tion into arginine buffer (100 mm TRIS, 400 mml -arginine, 2 mm
EDTA, 5 mm reduced glutathione, 0.5 mm oxidized glutathione,
0.1 mm phenylmethylsulfonyl fluoride), and the solution was incu-
bated for a further 12 h. The diluted protein was concentrated by
using Kvick cross filtration equipment with cellulose membranes
and with a 5000 kDa molecular weight cut off (GE Healthcare) and
the monomeric form purified by using a Superdex 75-filled Hiload
16/66 size-exclusion column (Amersham Biosciences) equilibrated
with HEPES buffer (25 mm HEPES, 50 mm KCl, 0.1% NaN3, pH 7.4).
The monomeric form was concentrated to final stock concentra-
tion by using Vivaspin Ultrafiltration devices (Sartorious, Epsom,
UK). The concentration of the protein samples was determined
spectrophotometrically to be 280 nm (A
1c m
1% =16.91). The purity of
both fibrils and inclusion bodies was confirmed by SDS-PAGE fol-
lowing solubilization in urea (Figure S1).
Formation of b2m fibrils: Fibrils composed of b2m were prepared
by acid precipitation. Monomeric b2m (84 mm b2m, 25 mm HEPES,
50 mm KCl, pH 7.4) was mixed 1:1 with a low-pH sodium citrate
buffer (50 mm sodium citrate, pH 1.6) to a final pH of 2.5. The solu-
tion was incubated at 378C with 200 rpm orbital shaking for
1 week. Fibril formation was confirmed by a Congo Red spectro-
photometric assay that showed a characteristic shift in absorbance
from 403 to 541 nm (data not shown). Fibril formation was also
determined by a Thioflavin T fluorescence assay, with lex=420 nm
by monitoring the increase in emission at 485 nm upon fibril for-
mation. Analysis of the fibrillar material by negative-stain electron
microscopy revealed extended fibrillar structures consistent with
previous studies. Prior to NMR analysis, the b2m fibrils were har-
vested by ultracentrifugation (98400g, 60 min).
Solid-state NMR studies: Spectra were acquired on an 850 MHz
Avance Spectrometer (Bruker) equipped with a 3.2 mm triple reso-
nance CP-MAS probe. Typically the b2m inclusion bodies and fibrils
were composed of approximately 50–70% water w/w as deter-
mined by lyophilization; this permitted the packing of 10 mg of
protein into a 3.2 mm rotor for NMR analysis. Data were acquired
with 15 kHz MAS with a sample temperature of approximately 58C
(temperature set to 108C to compensate for frictional and radio
frequency (rf) heating).
13C homonuclear correlation spectra were
acquired on a standard proton-driven spin diffusion (100 ms) ex-
change experiment.
[7] Carbon magnetization was excited by adia-
batic cross polarization with a carbon rf amplitude centered on
75 kHz. Two-dimensional spectra were acquired phase sensitively
with a time-proportional phase increment (TPPI) in the indirect di-
mension and with a 65 kHz spectral width in each dimension. A
total 600 t1 increments were acquired in the indirect dimension
with 64 scans per increment and a 2.5 s recycle delay. During both
direct and indirect dimensions SPINAL proton decoupled was ap-
plied with an rf amplitude of 120 kHz. The data were processed in
nmrPipe
[13] and analysed in CCPN.
[14] A sine-bell-squared function
was applied to both dimensions prior to zero filling to 4096 points
in each dimension and Fourier transformation.
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